Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues.This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

Echocardiography Related COVID-19 Research Presented at ASE 2021

Getty Images

News | Cardiovascular Ultrasound | June 29, 2021
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021...
Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.

Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.

News | Congenital Heart | June 29, 2021
June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure...
According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.
News | Cardiac Imaging | May 12, 2021
May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27...
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
News | Contrast Media | May 11, 2021
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (...
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe.

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very...
RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced acute kidney injury (CI-AKI) for patients with kidney disease who undergo interventional cath lab procedures. Results of the 700 patient, randomized, investigator-driven REMEDIAL III Trial presented at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. #TCT19 #TCT2019
News | October 04, 2019
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced...
Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick

News | Magnetic Resonance Imaging (MRI) | August 28, 2019
August 28, 2019 — A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
August 7, 2019 — Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic...
Videos | Contrast Media | June 28, 2019
Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax,...
Videos | Cath Lab | June 26, 2019
Thomas Porter, M.D., FASE, the Theordore F. Hubbard Distinguished Chair of Cardiology and a professor of medicine at...
Iodine-based CT contrast with ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs. It is not clear that contrast caused contract induced nephrapathy (CIN), also referred to as acute kidney injury (AKI) or contrast-associated acute kidney injury (CAAKI). Photo by Dave Fornell

Iodine-based CT contrast ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs. Photo by Dave Fornell

Feature | Contrast Media | May 31, 2019 | Dave Fornell, Editor
Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a...
The individuals who appear are for illustrative purposes only. All persons depicted are models and not real patients or healthcare professionals.

Pass-through status and new CPT codes are expectred to boost usage of contrast-enhanced ultrasound procedures. The individuals who appear are for illustrative purposes only. All persons depicted are models and not real patients or healthcare professionals.

Case Study | Cardiovascular Ultrasound | May 29, 2019
As part of the Consolidated Appropriations Act of 2018, pass-through payment status for LUMASON® (sulfur hexafluoride...
DyeMINISH Multi-center Global Patient Registry Launched
News | Contrast Media | May 09, 2019
May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
March 7, 2019 — National and international ultrasound societies are urging the U.S. Food and Drug Administration to...